Dr. Megan Elizabeth Phillips is a pharmacist who is specialized in Critical Care in Canton, Georgia. Patients can reach her at 450 Northside Cherokee Blvd, Pharmacy Department, Canton or contact her on 770-224-1200. Active license number of Dr. Megan Elizabeth Phillips is RPH028426 for Critical Care in Georgia. Dr. Megan Elizabeth Phillips is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists, as integral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients.
Complete Profile:
Dr. Megan Elizabeth Phillips speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Megan Elizabeth Phillips are as mentioned below.
NPI Number:
1326846353
NPI Enumeration Date:
05 Mar, 2025
NPI Last Update On:
05 Mar, 2025
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Megan Elizabeth Phillips are as mentioned below.
Specialization
License Number
State
Status
Critical Care
RPH028426
Georgia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
450 Northside Cherokee Blvd, Pharmacy Department Canton, Georgia
Zip:
30115
Phone Number:
770-224-1200
Fax Number:
--
Patients can reach Dr. Megan Elizabeth Phillips at 450 Northside Cherokee Blvd, Pharmacy Department, Canton, Georgia or can call on phone at 770-224-1200.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.